Study Shows Growing Acceptance of Statin Drug Usefulness for Dementia

March 30, 2005

Nymox Pharmaceutical's U.S. and global patent rights and prospects for the use of statin drugs for treating, preventing or reducing the risk of Alzheimer's disease in patients at risk for the disease have been strongly bolstered by newly published study data showing growing acceptance of the drugs' indications for patients at risk for dementia.

Up to half of clinicians favor the use of statins for treating patients at risk for developing cognitive impairment and dementia because of vascular risk factors according to a new study published in the Journal of Neurological Sciences.

Researchers at the University of Leister surveyed 177 practicing doctors in rural England about the role of statins in the management of patients at risk for developing cognitive impairment or with cognitive impairment related to vascular disease or factors and found that nearly half felt that statins have an important role in helping patients at risk of developing cognitive impairment.